Vaccine and Treatment Evaluation Units: Phase I Clinical Trial to Evaluate a Zika Vaccine Candidate

疫苗和治疗评估单位：评估寨卡候选疫苗的 I 期临床试验

• 批准号: 10683482
• 负责人: SARAH GEORGE
• 金额: $ 72.7万
• 依托单位: SAINT LOUIS UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-09-15 至 2023-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10683482
• 关键词: Communicable Diseases; Conduct Clinical Trials; Contracts; Evaluation; Individual; Phase I Clinical Trials; Resources; Vaccines; Zika virus vaccine; combat; design; programs; vaccine candidate; Communicable Diseases; Conduct Clinical Trials; Contracts; Evaluation; Individual; Phase I Clinical Trials; Resources; Vaccines; Zika virus vaccine; combat; design; programs; vaccine candidate

This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases.

该计划由学术中心和组织内的一个个人合同组成，这些联合为设计和行为提供了现成的资源，以评估有前途的产品来打击传染病。